TR200906506A2 - Telmisartan içeren katı dozaj formları. - Google Patents

Telmisartan içeren katı dozaj formları.

Info

Publication number
TR200906506A2
TR200906506A2 TR2009/06506A TR200906506A TR200906506A2 TR 200906506 A2 TR200906506 A2 TR 200906506A2 TR 2009/06506 A TR2009/06506 A TR 2009/06506A TR 200906506 A TR200906506 A TR 200906506A TR 200906506 A2 TR200906506 A2 TR 200906506A2
Authority
TR
Turkey
Prior art keywords
dosage forms
solid dosage
forms containing
containing telmisartan
telmisartan
Prior art date
Application number
TR2009/06506A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/06506A priority Critical patent/TR200906506A2/tr
Priority to PCT/TR2010/000168 priority patent/WO2011025467A1/en
Publication of TR200906506A2 publication Critical patent/TR200906506A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

Mevcut buluş, aktif ajan olarak telmisartan ve hidroklorotiazid içeren tek katmanlı oral dozaj formlarına, bu formların kompozisyonlarına ve bu dozaj formlarının hazırlanmasına yönelik usullere ilişkindir.
TR2009/06506A 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları. TR200906506A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.
PCT/TR2010/000168 WO2011025467A1 (en) 2009-08-24 2010-08-13 Solid dosage forms comprising telmisartan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.

Publications (1)

Publication Number Publication Date
TR200906506A2 true TR200906506A2 (tr) 2011-03-21

Family

ID=43333029

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/06506A TR200906506A2 (tr) 2009-08-24 2009-08-24 Telmisartan içeren katı dozaj formları.

Country Status (2)

Country Link
TR (1) TR200906506A2 (tr)
WO (1) WO2011025467A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2706292A1 (en) * 2010-05-28 2011-11-28 Pharmascience Inc. A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide
CN107501192A (zh) * 2017-08-15 2017-12-22 中国科学院上海药物研究所 替米沙坦与氢氯噻嗪的共晶
CN111249243A (zh) * 2020-03-18 2020-06-09 重庆康刻尔制药有限公司 一种替米沙坦片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
ES2298351T5 (es) 2002-01-16 2012-01-26 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Método para producir un comprimido farmacéutico de dos capas que comprenden telmisartán e hidroclorotiazida.
US9029363B2 (en) * 2003-04-30 2015-05-12 Boehringer Ingelheim International Gmbh Telmisartan sodium salt pharmaceutical formulation
US20060159747A1 (en) 2004-12-17 2006-07-20 Boehringer Ingelheim International Gmbh Telmisartan and hydrochlorothiazide combination therapy
EP1827424A1 (en) 2004-12-17 2007-09-05 Boehringer Ingelheim International GmbH Combination therapy comprising telmisartan and hydrochlorothiazide
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
SI22297A (sl) * 2006-06-23 2007-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava soli telmisartana

Also Published As

Publication number Publication date
WO2011025467A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
AR081681A1 (es) METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
GEP20146197B (en) New compounds
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
UA114087C2 (xx) Похідні піридину
UA108101C2 (xx) Похідні n3-заміщених n1-сульфоніл-5-фторпіримідинонів
MX2011009847A (es) Agentes antihelminticos y su uso.
CY1118062T1 (el) Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης
MX2011003473A (es) Composiciones para el cuidado bucal.
MX2013001677A (es) Formulaciones estables de linaclotida.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MY153805A (en) Nicotine containing soft gelatin pastilles
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
TR201903026T4 (tr) S100a4 anti̇korlari ve bunlarin terapöti̇k kullanimlari.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2011012993A (es) Bencimidazoles, benzotiazoles y benzoxazoles, sustituidos.
MX2013006418A (es) Derivados de oxazolil-metileter como agonistas del receptor de alx.
UA106889C2 (uk) Похідні n1-ацил-5-фторпіримідинону
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
UY32520A (es) Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
EA201290229A1 (ru) Производные спиролактама и их применение
EA201270377A1 (ru) Стабильные композиции sns-595 и способы их получения
TR200906506A2 (tr) Telmisartan içeren katı dozaj formları.